(Press-News.org) New Rochelle, NY, June 6, 2013— Immunocompromised mice, created by inactivating the genes that would allow them to recognize and attack donor cells or organs, are critical for studies of bone marrow reconstitution. A more rapid and reliable technique for identifying these mice in breeding colonies is described in an article in BioResearch Open Access, a peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.
Alejandro Ferrer, Adam Schrum, and Diana Gil, College of Medicine, Mayo Clinic (Rochester, MN), designed a simple method for identifying mice with specific gene deletions or replacements, using a DNA amplification technique called polymerase chain reaction, or PCR. They describe the use of this approach in the article "A PCR-Based Method to Genotype Mice Knocked Out for All Four CD3 Subunits, the Standard Recipient Strain for Retrogenic TCR/CD3 Bone Marrow Reconstitution Technology."
"This technical report describes for the first time a simple PCR-based screen to identify TCR/CD3 knockout mice," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. "This rapid method
will provide a valuable tool for all researchers using TCR/CD3 retrogenesis."
INFORMATION:
About the Journal
BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMedCentral. All journal content is available on the BioResearch Open Access website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including DNA and Cell Biology, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
New screening method quickly identifies mice bred for bone marrow regeneration studies
2013-06-06
ELSE PRESS RELEASES FROM THIS DATE:
NASA sees heavy rainfall in tropical storm Andrea
2013-06-06
NASA's TRMM satellite passed over Tropical Storm Andrea right after it was named, while NASA's Terra satellite captured a visible image of the storm's reach hours beforehand. TRMM measures rainfall from space and saw that rainfall rates in the southern part of the storm was falling at almost 5 inches per hour.
NASA's Terra satellite passed over Tropical Storm Andrea on June 5 at 16:25 UTC (12:25 p.m. EDT) and the Moderate Resolution Imaging Spectroradiometer or MODIS instrument, captured a visible image of the storm. At that time, Andrea's clouds had already extended ...
Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration
2013-06-06
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional ...
Rewinding development: A step forward for stem cell research
2013-06-06
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells. This significant discovery, published in the journal Cell Reports today, has the potential to shed new light on placenta related disorders that can lead to problematic pregnancies and miscarriages.
Embryonic stem cells can make all kinds of adult cells in the human body such as muscle, blood or brain cells. However, these ...
Research reveals Europe winning war on undeclared work
2013-06-06
Research from the University of Sheffield has found that the wider range of policy approaches and measures which have been introduced in all EU Member States over the past five years have had a significant impact on preventing businesses and people from engaging in undeclared work.
The research, led Professor Colin Williams from the University of Sheffield, found an incremental decline in the size of the undeclared economy from the equivalent of 22.3 percent of GDP in 2003 to 18.4 percent by 2012 - although with big differences between countries, revealing a clear north-south ...
Promising material for lithium-ion batteries
2013-06-06
This news release is available in German.
Loading a lithium-ion battery produces lithium atoms that are taken up by the graphite layers of the negative electrode. However, the capacity of graphite is limited to one lithium atom per six carbon atoms. Silicon could take up to ten times more lithium. But unfortunately, it strongly expands during this process – which leads to unsolved problems in battery applications.
Looking for an alternative to pure silicon, scientists at the Technische Universitaet Muenchen have now synthesized a novel framework structure consisting ...
2011 Draconid meteor shower deposited a ton of meteoritic material on Earth
2013-06-06
Every 6.6 years, the comet Giacobini-Zinner circulates through the inner solar system and passes through the perihelion, the closest point to the Sun of its orbit. Then, the comet sublimates the ices and ejects a large number of particles that are distributed in filaments. The oldest of these particles have formed a swarm that the Earth passes trough every year in early October. The result is a Draconid meteor shower –meteors from this comet come from the northern constellation Draco–, which hits the Earth's atmosphere at about 75,000 km/h, a relatively slow speed in comparison ...
MRI study: Breastfeeding boosts babies' brain growth
2013-06-06
PROVIDENCE, R.I. [Brown University] — A new study by researchers from Brown University finds more evidence that breastfeeding is good for babies' brains.
The study made use of specialized, baby-friendly magnetic resonance imaging (MRI) to look at the brain growth in a sample of children under the age of 4. The research found that by age 2, babies who had been breastfed exclusively for at least three months had enhanced development in key parts of the brain compared to children who were fed formula exclusively or who were fed a combination of formula and breastmilk. The ...
Human Argonaute proteins: To slice or not to slice?
2013-06-06
Cold Spring Harbor, N.Y. – Human Argonautes (hAgo), are key proteins involved in a process known as RNA interference. RNAi, as it is often called, is a mechanism that cells use to regulate gene expression. Human Argonaute-2 (hAgo2) is known as "slicer" for its unique ability among the 4 human Argonaute proteins to directly cut messenger RNA -- which carries the information coded in genomic DNA to make a protein -- and thus disable "messages" generated from genes.
The atomic resolution structure of hAgo2 solved previously, revealed the active site, a region of the enzyme ...
Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added
2013-06-06
CHAPEL HILL, N.C. - While aspirin has been shown to be effective in preventing heart attacks in men, it also increases the risk of gastrointestinal bleeding and possibly stroke, even at low doses. As such, national guidelines suggest that aspirin be used for prevention only in men at higher risk for cardiovascular events, so that the benefits of aspirin are greater than its adverse effects.
Recent data suggest that aspirin may also be effective for reducing cancer deaths. Would the possible combined health benefits of reducing heart attacks and cancer outweigh the risks ...
Unusual antibodies in cows suggest new ways to make therapies for people
2013-06-06
LA JOLLA, CA – June 6, 2013 – Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) focusing on an extraordinary family of cow antibodies points to new ways to make human medicines.
"These antibodies' structure and their mechanism for creating diversity haven't been seen before in other animals' antibodies," said Vaughn V. Smider, assistant professor of cell and molecular biology at TSRI and principal investigator ...